Glucon (www.glucon.com) is developing a pipeline of automated, continual, blood glucose (sugar) monitoring devices for home and clinical use. Glucon was founded in 2000 by Israeli scientists including Company President Ron Nagar. The company's flagship product, Aprise, is currently undergoing extensive clinical trials. Seed financing was provided by InnoMed Ventures. Additional investors include Giza Venture Capital, Infinity Venture Capital Fund, Ascend Technology Ventures, and several others.
| Website | http://www.glucon.com |
| Revenue | $7.8 million |
| Employees | View employees |
| Founded | 2000 |
| Address | 2425 55th St Ste 100B, Boulder, Colorado 80301, US |
| Phone | +972 3-934-7660 |
| Industry | Manufacturing General, Marketplace, Manufacturing, Commerce and Shopping, Medical, Health Care, Medical Device |
| Competitors | HealthifyMe, Metabolic Management Inc, Diabetes Checkpoint (view competitors) |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 334 Companies, NAICS Code 33 Companies |
Looking for a particular Glucon employee's phone or email?
Glucon Questions
The Glucon annual revenue was $7.8 million in 2026.
Glucon is based in Boulder, Colorado.
The NAICS codes for Glucon are [334, 33].
The SIC codes for Glucon are [384, 38].
